
The Newsroom
Item 1 of 3

AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
Item 2 of 3

Historic telesurgery connects Central Florida and Angola in world-first medical breakthrough
Item 3 of 3

New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Recent Stories at AdventHealthMD
-
-
Clinical Excellence
An incredible journey through two open heart surgeries at AdventHealth
-
Innovation
AdventHealth Launches Research Study to Evaluate an Evidence-based Intervention Designed to Address Physician Burnout
-
Clinical Excellence
AdventHealth Orlando is the First in Central Florida to Randomize a Patient in the Global ALLAY-HF Study for Alleviating Heart Failure Symptoms
-
Innovation
African Americans at Higher Risk for Cardiac Issues, AdventHealth Physician Says Small Changes Will Reduce Risk
-
Innovation
AdventHealth Physician and Team Become First in the World to Create and Perform New Endoscopic Procedure Allowing a Patient to Eat Normally Again
-
Innovation
AdventHealth Orlando Offers New Program Utilizing Combined Approach to Treat Atrial Fibrillation
-
Innovation
AdventHealth First in Central Florida to Implant Dual-Chamber Leadless Pacemaker as Part of AVEIR DR i2i Clinical Trial
-
Clinical Excellence
AdventHealth for Children Performs Florida’s First Alterra Adaptive Prestent and Valve Implant on a Patient with Congenital Heart Disease